News

Akebia Therapeutics Unveils Key Research Findings at ASN Kidney Week

Akebia Therapeutics Unveils Key Research Findings at ASN Kidney Week

Akebia Therapeutics at ASN Kidney Week 2025

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a dedicated biopharmaceutical organization specializing in kidney disease, proudly announces its participation in the American Society of Nephrology Kidney Week 2025. This major event is a hotspot for nephrology professionals and takes place in Houston, emphasizing the latest findings in kidney health.

Noteworthy Presentations by Akebia

During this esteemed gathering, notable presentations will highlight the latest clinical data related to vadadustat, Akebia's pioneering treatment for anemia stemming from chronic kidney disease (CKD). Dr. Glenn M. Chertow of Stanford University will lead the presentation of a critical win odds analysis related to mortality and hospitalization among patients enrolled in the INNO2VATE trials, a global Phase 3 clinical program aimed at assessing the efficacy of vadadustat.

Understanding Vadadustat

Vadadustat operates as a hypoxia-inducible factor prolyl hydroxylase inhibitor, influencing the body’s natural responses to low oxygen levels. This treatment notably stimulates the production of erythropoietin, crucial for hemoglobin and red blood cell production, thus managing anemia in CKD patients. Following its U.S. approval for use among adults on dialysis, Akebia continues to expand on its promising research.

Engagement with the Nephrology Community

Steven Burke, MD, Senior Vice President and Chief Research & Development Officer at Akebia, shared insights on their ongoing commitment: "Our engagement with the nephrology community plays a critical role in clarifying the treatment landscape. Achieving transparent data-sharing guarantees that healthcare professionals are equipped with essential knowledge to make informed therapeutic decisions."

Key Oral Presentation Details

Among the highlights of the ASN Kidney Week will be an oral presentation discussing:

Win-Odds Analysis of Deaths and Hospitalization in Patients Taking Vadadustat or Darbepoetin Alfa for CKD-related Anemia Undergoing Dialysis
Presenter: Glenn M. Chertow, MD
Session Date/Time: November 6, 2025; 4:30 PM to 6:00 PM
Session Room: Room 351D (Convention Center)

Poster Presentations at ASN Kidney Week

Additionally, Akebia will feature several poster presentations relevant to vadadustat:

Model-Based VAFSEO Starting Dose Recommendations in Dialysis-Dependent CKD Patients
Poster #: TH-PO902
November 6, 2025; 10:00 AM-12:00 PM CDT

Vadadustat Outcomes In-Center Experience (VOICE) Study: A Pragmatic Randomized Controlled Trial Testing Safety of Three Times Weekly Vadadustat
Poster #: FR-PO0204
November 7, 2025; 10:00 AM-12:00 PM CDT

Consistency of the Estimate of Responsiveness of Vadadustat vs. Darbepoetin
Poster #: FR-PO0202
November 7, 2025; 10:00 AM-12:00 PM CDT

Three Times Weekly In-Center Vadadustat vs. Standard Care Erythropoiesis-Stimulating Agent for CKD-Related Anemia in Patients Undergoing Dialysis (VOCAL)
Poster #: INFO10-FR
November 7, 2025; 10:00 AM-12:00 PM CDT

About Akebia Therapeutics

Founded in 2007, Akebia Therapeutics is intent on transforming the treatment landscape for those affected by kidney disease. With headquarters located in Cambridge, Massachusetts, the organization focuses on providing innovative, evidenced-based solutions. Interested individuals can find more about Akebia's mission by visiting their website.

About Vafseo (vadadustat) Tablets

As a once-daily oral treatment, Vafseo serves as a valuable option for managing anemia in CKD patients, activated through the body’s natural mechanisms to boost red blood cell production. It is notably available in over 37 countries.

Frequently Asked Questions

What is Akebia Therapeutics?

Akebia Therapeutics is a biopharmaceutical company focused on improving the lives of those with kidney disease through innovative treatments and research.

What will Akebia present at ASN Kidney Week 2025?

Akebia will present key findings from clinical data on vadadustat, focusing on its benefits for CKD-related anemia.

Who is leading the oral presentation?

Dr. Glenn M. Chertow of Stanford University will present a crucial analysis on the impact of vadadustat.

What is Vafseo?

Vafseo (vadadustat) is a medication designed to manage anemia in CKD patients by enhancing the body’s natural production of red blood cells.

Where can I learn more about Akebia?

For more information, visit Akebia Therapeutics’ official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 530

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 64

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 187

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 93

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 617

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 83

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 103

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 128

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 518

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 337

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

Agibank's Impressive Financial Growth and Market Strategies

Updated Category News Views 269

Agibank Reports Remarkable Financial Performance Agibank, the innovative digital bank, has showcased strong financial performance, marking substantial growth in its metrics. The bank has effectively combined the efficiency of digital banking with the valuable presence of physical locations, allowing it to flourish in a competitive market. Net Income and Loan Portfolio...

Continue Reading
Join Wisner Baum for the Eaton Wildfire Town Hall Event

Updated Category News Views 261

Join Wisner Baum for the Eaton Wildfire Town Hall Event Wisner Baum LLP is excited to present an in-person Eaton Wildfire Informational Town Hall, offering invaluable insights and updates. This engaging event will take place on February 19, from 6 p.m. to 8 p.m. PST at The Westin Pasadena. It's a perfect opportunity for the community to gather and discuss pressing issues...

Continue Reading
UK Inflation Rises to 2.6% in Recent Economic Update

Updated Category News Views 132

UK Inflation Trends in November Recent data reveals that British inflation has seen an increase, reaching an annual rate of 2.6% in November. This marks a rise from the previous rate of 2.3% observed in October, highlighting a notable shift in the economic climate. Understanding the Inflation Increase The upward trend in inflation aligns with predictions from economists,...

Continue Reading
Pan American Silver's Strategic Acquisition of MAG Silver Complete

Updated Category News Views 150

Pan American Silver Completes the Acquisition of MAG Silver In an exciting development for the mining industry, Pan American Silver Corp. (NYSE: PAAS) has officially completed its acquisition of MAG Silver Corp. (NYSE American: MAG). This strategic move strengthens Pan American’s position in the silver market, bolstering its already robust portfolio. This acquisition...

Continue Reading
El Pollo Loco: A Fresh Look and Bold Expansion Ahead

Updated Category News Views 294

Exciting Transformation for El Pollo Loco El Pollo Loco, a beloved name in the fire-grilled chicken restaurant scene, is taking bold steps as it approaches its 50th anniversary. Recently, the company unveiled a new restaurant design that combines modern aesthetics with familiar brand elements, showcasing a commitment to innovation and efficiency. Introducing a...

Continue Reading